The Novozymes Report 2010

Audited by PwC

Novozymes’ ambition is to provide a report that integrates financial and sustainability data. We have been working on integrated reporting for many years, as this reflects the way we operate our business.

The Novozymes Report 2010 is available in English in a full online version at The written online report is supplemented with a series of videos adding perspective and insight into Novozymes’ performance in 2010. To further enhance the online reporting universe, we have an integrated feature called My Report that enables you to compile a full or customized pdf download of the report. We hope that you will find this feature useful. A printed version of the full report is no longer available, but a printed extract of the report is still published in both English and Danish. The extract will be available at the Annual Shareholders’ Meeting.

The reporting website is dedicated to the Novozymes Report 2010 and other information relevant to our shareholders and financial stakeholders, but is also a mine of information for anyone else with an interest in Novozymes.

All photos in the report feature Novozymes employees from around the world, illustrating both our global presence and our human touch. It is our 5,432 employees who make Novozymes the world leader in bioinnovation.

Editorial team

Editor  Kirsten Laugesen, Corporate Communications,, tel. +1 919 494 3361
Finance  Jens Breitenstein, Finance,, tel. +45 4446 1087
Jan Paulsen, Finance,, tel. +45 4446 3208
Investor Relations Tobias Bjorklund, Investor Relations,, tel. +45 4446 8682
Thomas Steenbech Bomhoff, Investor Relations,, tel. +1 919 494 3483
Sustainability  Mette Gyde Møller, Sustainability Development,, tel. +45 4446 0434
Assistance  Tanja Bengtsson, Finance,, tel. +45 4446 1239
Text The editorial team from Novozymes, headed by Corporate Communications
Photos Niclas Jessen
Design & web Bysted A/S
Editing, proofreading
& Danish translation

Borella projects

© Novozymes A/S

My Report

0 pages added

MyReport Videos
It is time to rethink tomorrow.
How Novozymes rethinks tomorrow